Jack W. Schuler - Jun 9, 2023 Form 4 Insider Report for Accelerate Diagnostics, Inc (AXDX)

Role
Director, 10%+ Owner
Signature
/s/ David Patience, attorney-in-fact
Stock symbol
AXDX
Transactions as of
Jun 9, 2023
Transactions value $
$40,380,432
Form type
4
Date filed
6/20/2023, 04:10 PM
Previous filing
Jun 1, 2023
Next filing
Jun 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXDX Common Stock Award $4M +4.88M +26.03% $0.82* 23.6M Jun 9, 2023 By Jack W. Schuler Living Trust F1, F2
transaction AXDX Common Stock Award $36.4M +34.3M +145.34% $1.06* 57.9M Jun 9, 2023 By Jack W. Schuler Living Trust F2, F3
holding AXDX Common Stock 55K Jun 9, 2023 By Spouse F4
holding AXDX Common Stock 75.9K Jun 9, 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares purchased by the reporting person from Accelerate Diagnostics, Inc. (the "Issuer") in connection with an offering by the Issuer exempt from registration pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, and approved by the Issuer's board of directors.
F2 The reporting person has sole voting and dispositive power with respect to such shares in his capacity as trustee of the Jack W. Schuler Living Trust.
F3 Represents shares issued to the reporting person in connection with the Issuer's repurchase of a secured promissory note previously issued by the Issuer in favor of the reporting person in an aggregate principal amount of $34,933,500, plus accrued interest, and approved by the Issuer's board of directors.
F4 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.